Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, November 10, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
City Therapeutics Announces Submission of Application for Clinical Trial of CITY-FXI, an Investigational RNAi Anticoagulant
Life Sciences Times
-
November 10, 2025
Pharma
AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome
Life Sciences Times
-
November 7, 2025
Pharma
Astria Therapeutics Reports Final Positive Results from All Enrolled HAE Patients in ALPHA-STAR Phase 1b/2 Trial of Navenibart
Life Sciences Times
-
November 6, 2025
Pharma
Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis
Life Sciences Times
-
October 31, 2025
Pharma
Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration
Life Sciences Times
-
October 28, 2025
Pharma
Takeda Becomes First Enterprise to Achieve Diamond Tier Status as a Best in Resilience™ Certified Organization
Life Sciences Times
-
October 27, 2022
0
Pharma
Milla Pharmaceuticals Inc. and the Alter Pharma Group Announce First Paragraph IV Filing and Acceptance by FDA
Life Sciences Times
-
October 27, 2022
0
Pharma
Gilead Presents Real-World Evidence Reinforcing the Use of Biktarvy® for the Treatment of People Living With HIV With a Range of Comorbidities
Life Sciences Times
-
October 24, 2022
0
Pharma
Novaliq Announces FDA Acceptance of the New Drug Application for CyclASol® for the Treatment of Dry Eye Disease
Life Sciences Times
-
October 24, 2022
0
Pharma
Teva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® Tablets for the Treatment of Chorea Associated with Huntington’s Disease
Life Sciences Times
-
October 18, 2022
0
Pharma
Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for Cholestatic Pruritus
Life Sciences Times
-
October 14, 2022
0
Pharma
CHMP recommends conditional marketing authorization for Spesolimab as first in class treatment option for generalized pustular psoriasis flares
Life Sciences Times
-
October 14, 2022
0
Pharma
CANbridge-UMass Chan Medical School Gene Therapy Research in Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 29th Annual Congress
Life Sciences Times
-
October 14, 2022
0
Pharma
4Moving Biotech Announces First Patient Enrolled in Phase I Clinical Trial on Osteoarthritis
Life Sciences Times
-
October 14, 2022
0
Pharma
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
Life Sciences Times
-
October 12, 2022
0
Pharma
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Gilead’s Trodelvy® for Pre-Treated HR+/HER2- Metastatic Breast Cancer
Life Sciences Times
-
October 11, 2022
0
Pharma
ADOCIA Announces Exceptional Weight Loss for Obese People with Type 1 Diabetes using M1Pram in a post-hoc analysis
Life Sciences Times
-
October 6, 2022
0
1
...
38
39
40
...
83
Page 39 of 83
Most Read
Tandem Mobi Receives FDA Clearance for Use with Android Smartphones
November 10, 2025
Earned Expands Services with Addition of Dental & Medical Counsel, Bringing Specialized Legal Support for Healthcare Professionals
November 10, 2025
Dr. Nina Kottler Named Chief Medical AI Officer of Mosaic Clinical Technologies
November 10, 2025
Kaneka Expands Global Availability of i-ED Coil with European Launch
November 10, 2025